Page 101 - 《中国药房》2023年17期
P. 101

·药物与临床·


          1 例儿童输注万古霉素致全血细胞减少症合并迟发型药物热的
          病例分析
                        Δ


                                          1
                                                   3 #
                 1*
          陈晓旭 ,吴非燃 ,李洪盟 ,荆自伟 ,张 辉 (1.郑州大学第一附属医院药学部,郑州 450052;2.河南省洛阳
                          2
                                  1
          正骨医院脊柱微创外科,郑州 450016;3.郑州大学第一附属医院小儿外科,郑州 450052)
          中图分类号  R969.3;R978.1      文献标志码  A      文章编号  1001-0408(2023)17-2139-05
          DOI  10.6039/j.issn.1001-0408.2023.17.16

          摘  要  目的  准确识别万古霉素较罕见的药品不良反应(ADR)——全血细胞减少症,以促进该药的安全使用。方法 通过1例化
          脓性髋关节炎患儿静脉输注万古霉素后发生全血细胞减少症合并迟发型药物热的病例报告,采用Naranjo评分结合文献资料,评
          估该ADR与治疗药物的关系及其可能的发生机制,提出儿童患者合理使用万古霉素的建议。结果与结论 该患儿发生的全血细胞
          减少症合并迟发型药物热与万古霉素的关联性为“很可能”。临床上全血细胞减少症合并迟发型药物热与感染加重导致的发热、
          血细胞减少较难区分,医护人员应提高对全血细胞减少症等万古霉素较罕见ADR的警觉性,药师应协助医护人员及时甄别ADR。
          儿童输注万古霉素初始剂量宜从60 mg/(kg·d)开始,且应在首次用药后48 h进行血药浓度监测并及时调整剂量,使万古霉素谷浓
          度维持在5~15 mg/L,以防止因血药浓度过高导致ADR的发生;对于万古霉素使用超过1周的患儿,应定期复查血常规,一旦发
          生全血细胞减少应立即停药,并根据情况给予对症治疗。
          关键词  万古霉素;儿童;全血细胞减少症;迟发型药物热;病例分析


          Analysis of a case of pancytopenia complicated with delayed drug fever induced by vancomycin infusion in
          a child
                                                               1
                                                  1
                       1
                                   2
          CHEN Xiaoxu ,WU Feiran ,LI Hongmeng ,JING Ziwei ,ZHANG Hui (1.  Dept.  of  Pharmacy,  the  First
                                                                            3
          Affiliated  Hospital  of  Zhengzhou  University,  Zhengzhou  450052,  China;2.  Dept.  of  Minimal  Invasive  Spinal
          Surgery, Luoyang Orthopedic-Traumatological Hospital of Henan Province, Zhengzhou 450016, China;3. Dept.
          of Pediatric Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China)
          ABSTRACT   OBJECTIVE To accurately identify the rare adverse drug reactions (ADR) of vancomycin-pancytopenia in order to
          promote  its  safe  use.  METHODS  Through  a  case  report  of  a  child  with  suppurative  hip  arthritis  who  developed  pancytopenia
          combined with  delayed drug  fever caused by  intravenous infusion  of  vancomycin,Naranjo score  method and  related literature  were
          used to summarize the association between the ADR and vancomycin and its possible mechanism, and suggestions for rational use
          of  vancomycin  in  pediatric  patients  were  put  forward.  RESULTS  &  CONCLUSIONS  The  association  of  pancytopenia  combined
          with  delayed  drug  fever  and  vancomycin  in  this  child  is “very  likely”.  In  clinical  practice,  it  is  difficult  to  distinguish  between
          pancytopenia  combined  with  delayed  drug  fever  from  fever  and  hematopenia  caused  by  aggravation  of  infection.  Medical  staff
          should  increase  their  awareness  of  vancomycin  rare  ADR  such  as  pancytopenia,  and  pharmacists  should  assist  medical  staff  in
          timely  screening  for  ADR.  The  initial  dose  of  vancomycin  infusion  for  children  should  start  from  60  mg/(kg·d),and  the  blood
          concentration  should  be  monitored  48  h  after  the  first  infusion  and  the  dose  should  be  adjusted  in  time  to  maintain  the  valley
          concentration of vancomycin at 5-15 mg/L to prevent the occurrence of ADR caused by excessive blood concentration. For children
          who  have  been  using  vancomycin  for  more  than  one  week,the  blood  routine  should  be  rechecked  regularly.  Once  pancytopenia
          occurs,the drug should be stopped immediately,and symptomatic treatment should be given according to the situation.
          KEYWORDS    vancomycin; children; pancytopenia; delayed drug fever; case analysis

             Δ 基金项目 国家自然科学基金项目(No.82003956);河南省医学
          科技攻关计划(联合共建)项目(No.LHGJ20190277)                        万古霉素是一种糖肽类抗菌药物,临床主要用于治
             *第一作者 主管药师,硕士。研究方向:医院药学、临床药理。电                  疗革兰氏阳性球菌引起的严重感染,尤其是甲氧西林耐
          话:0371-66967015。E-mail:xiaoxuC_hust@163.com
                                                             药的金黄色葡萄球菌(methicillin-resistant Staphylococ‐
             # 通信作者 主治医师,硕士。研究方向:小儿骨科。电话:0371-
          66967252。E-mail:297069266@qq.com                   cus aureus,MRSA)引起的感染。其常见药品不良反应


          中国药房  2023年第34卷第17期                                              China Pharmacy  2023 Vol. 34  No. 17    · 2139 ·
   96   97   98   99   100   101   102   103   104   105   106